RE-LY: Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin
Euro Heart J
M. Böhm, M. Brueckmann, J. Eikelboom, M. Ezekowitz, M. Fräßdorf, Z. Hijazi, S. Hohnloser, F. Mahfoud, R. Schmieder, H. Schumacher, L. Wallentin, S. Yusuf
May 2020